Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial
Background: Retatrutide, an agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors, is in development for the treatment of obesity. We interviewed participants exiting a phase 2 trial to understand the impact of retatrutide on eating behaviors, physi...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-12-01
|
| Serier: | Obesity Pillars |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2667368125000646 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|